Effects of statins on liver fibrosis reversibility and activities of lysosomal exoglycosidases

Experimental and Clinical Hepatology

Volumn 3, Issue 1, 2007, Pages 14-17

  Lukivskaya, Oxana ^a   Knas, Małgorzata ^b   Dudzik, Danuta ^b   Borzym Kluczk, Małgorzata ^b   Lis, Ruslan ^a   Buko, Vyacheslav ^a   Zwierz, Krzysztof ^b  

^a INSTITUTE OF BIOCHEMISTRY   (Belarus)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

mannosidase; galactosidase; Liver fibrosis; Statins

Indexed keywords

ALPHA MANNOSIDASE; BETA GALACTOSIDASE; FLUINDOSTATIN; GLYCOSIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LYSOSOME ENZYME; PLACEBO; SIMVASTATIN; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; IMAGE ANALYSIS; LIVER FIBROSIS; LOW DRUG DOSE; MALE; NONHUMAN; RAT; STAINING;

EID: 34547866073     PISSN: 17343038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis. 2006; 10(3): 459-79.
2. Jackson J, Stein RA. Intensive statin therapy beneficial in heart emergencies Arch. Internal Med. 2006; 25.
3. Go AS, Little WC. Statins could aid heart failure patients J. Am Med Ass 2006; 1.
4. Furberg CD. "Natural statins and stroke fisk". Circulation 1999; 99: 185-188.
5. Tan A, Levrey H, Dahm C, et al. Lovastatin induces fibroblast apoptosis in vitro and in vivo: a possible therapy for fibroproliferative disorders. Am J Respir Crit Care Med 1999; 159: 220-227.
6. Rombouts K, Kisanga E, Hellemans K, Wielant A, Schuppan D, Geerts A. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol. 2003 May; 38(5): 564-72.
7. Ritzel U, Leonhardt U, Nather M, Schafer G, Armstrong VW, Ramadori G. Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers. J Hepatol. 2002 Apr; 36(4): 454-8.
8. Goren MP, Wright RK, Horowitz ME, Crom WR, Meyer WH: Urinary N-acetyl-β-D-glucossminidase and serum creatinine concentrations predict imparied excretion of methotrexate. J Clin Oncol, 1987, 5, 804-810.
9. Schachter H.: Biosynthetic controls that determine the branching and heterogeneity of protein bound oligosaccharides. Biochem Cell Biol, 1986, 64, 163-167.
10. Elsafi, M.E. Hultberg, B. Isaksson, A. Hagerstrand, J. Prytz, H. Stenram, U. Lysosomes and human liver disease: a biochemical and immunohistochemical study of β-hexosaminidase. Eur J Clin Chem Clin Biochem, 1994; 32, 669-673.
11. Severini, G. Alibertti, L.M. DiGirolamo, M. N-Acetyl-β-glucosaminidase isoenzymes in serum and urine of patients with Diabetes mellitus. Clin Chem, 1988; 34, 2430-2432.
12. Zoch-Zwierz, W. Winiecka, W. Tomaszewska, B. Wierciński, R. Activity of N-acetylo-β-D-hexosoaminidase NAG and isozymes in the children's urine with primitive and secondary hypertension. Wiad Lek 1992; 13-14, 498-502.
13. Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG, Riecken EO, Schuppan D. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 2000; 118: 1169-1178.
14. Zwierz K., Gindzieński A., Głowacka D., Porowski T.: The degradation of glycoconjugates in the human gastric mucous membrane. Acta Med Acad Sci Hung, 1981, 38, 145.
15. Abdel-Aziz G, Lebeau G, Rescan PY, Clement B, Rissel M, Deugnier Y, Campion JP, Guillouzo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990; 37: 1333-1342.
16. Watanabe T, Niioka M, Hozawa S, Kameyama K, Hayashi T, Arai M, Ishikawa A, Maruyama K, Okazaki I. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 2000; 33: 224-235.
17. Bruck K, Genina O, Aeed H, Alexiev R, Nagler A, Avni Y, Pines M. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology 2001; 33: 379-386.
18. Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M, Sugimachi K. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 2002; 17: 59-65.
19. Torres MI, Fernandez MI, Gil A, Rios A. Dietary nucleotides have cytoprotective properties in rat liver damaged by thioacetamide. Life Sci 1998; 62: 13-22.
20. Inagaki Y, Truter S, Bou-Gharios G, Garrett LA, de Crombrugghe B, Nemoto T, Greenwel P. Activation of proalpha2(I) collagen promoter during hepatic fibrogenesis in transgenic mice. Biochem Biophys Res Commun. 1998 Sep 29; 250(3): 606-11.
21. Drozdz M, Olczyk K, Kucharz E. Effect of anti-inflammatory steroids on the activity of selected lysosomal hydrolases in serum of rats with experimental liver fibrosis. Exp Clin Endocrinol. 1983; 82(1): 111-4.
22. Blinova TV, Solopaeva IM, Zharikova GV. Effect of choriogonine on the enzymatic activity of lysosomes in the cirrhotic liver in the rat Vopr Med Khim. 1982 Nov-Dec; 28(6): 41-5.
23. Weber W, Kehrer T, Gressner AM, Stuhlsatz HW, Greiling H. Changes in the catalytic activities of proteoglycan-degrading lysosomal enzymes in parenchymal and non-parenchymal liver cells and in serum during the development of experimental liver fibrosis. J Clin Chem Clin Biochem. 1983 May; 21(5): 287-93.
24. Nakashima A, Ohtawa M, Iwasaki K, Wada M, Kuroda N, Nakashima K. Inhibitory effects of fluvastain and its metabolites on the formation of several reactive oxygen species. Life Sci. 2001 Aug 10; 69(12): 1381-9.
25. Lopes-Virella MF, Mironova M, Stephan E, Durazo-Arvizu R, Virella G. Role of simvastatin as an immunomodulator in type 2 diabetes. Diabetes Care. 2004 Apr; 27(4): 908-13.
26. Oberti F, Pilette C, Rifflet H, Maiga MY, Moreau A, Gallois Y, Girault A, le Bouil A, Le Jeune JJ, Saumet JL, Feldmann G, Cales P. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol. 1997 Jun; 26(6): 1363-71.